Patients With High Levels of Circulating Endothelial Progenitor Cells (EPC) Following at Least Three Months of Anticoagulation for Unprovoked Venous Thromboembolism (VTE) Are at Low Risk of Recurrent VTE—Results From the ExACT Randomised Controlled Trial.

EClinicalMedicine - United Kingdom
doi 10.1016/j.eclinm.2019.11.011
Full Text
Abstract

Available in full text

Categories
Medicine
Date
Authors
Publisher

Elsevier BV


Related search